Literature DB >> 21815577

Management of combined bone defect and limb-length discrepancy after tibial chronic osteomyelitis.

Tang Liu1, Xiangsheng Zhang, Zhihong Li, Dan Peng.   

Abstract

Bone defects and leg shortening due to chronic osteomyelitis are rare yet challenging problems to treat. The aim of this study was to summarize our experience with a distraction osteogenesis technique performed with an external fixator for these conditions. Twenty-three consecutive patients with tibial bone defects and limb-length discrepancy caused by osteomyelitis were treated from January 1994 to January 2009. Thirteen boys and 10 girls had a mean age of 12.2 years (range, 8-16 years). Twenty of the 23 patients (87.0%) had undergone an unsuccessful bone grafting procedure. Mean amount of bone defect was 3.6 cm (range, 1.5-6.2 cm) as measured on plain radiographs. Mean leg-length discrepancy was 4.0 cm (range, 0-8.0 cm). All patients were followed for a mean of 116 months (range, 31-182 months). Mean external fixation index was 48.0 days/cm (range, 40.7-66.5 days/cm). Mean lengthening was 9.3 cm (range, 5.8-12.1 cm). Based on the criteria recommended by Paley et al, 16 bone results were excellent, 6 good, and 1 fair. Fifteen functional results were excellent, 7 good, 1 fair, and 0 poor. This study shows that distraction osteogenesis with an external fixator is an effective treatment for massive postosteomyelitis bone defects and leg shortening. Copyright 2011, SLACK Incorporated.

Entities:  

Mesh:

Year:  2011        PMID: 21815577     DOI: 10.3928/01477447-20110627-12

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  8 in total

1.  Repurposing the Nonsteroidal Anti-inflammatory Drug Diflunisal as an Osteoprotective, Antivirulence Therapy for Staphylococcus aureus Osteomyelitis.

Authors:  Andrew S Hendrix; Thomas J Spoonmore; Aimee D Wilde; Nicole E Putnam; Neal D Hammer; Daniel J Snyder; Scott A Guelcher; Eric P Skaar; James E Cassat
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

2.  Concurrent Local Delivery of Diflunisal Limits Bone Destruction but Fails To Improve Systemic Vancomycin Efficacy during Staphylococcus aureus Osteomyelitis.

Authors:  Thomas J Spoonmore; Caleb A Ford; Jacob M Curry; Scott A Guelcher; James E Cassat
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

Review 3.  The etiology of short stature affects the clinical outcome of lower limb lengthening using external fixation. A systematic review of 18 trials involving 547 patients.

Authors:  Seung-Ju Kim; Wendy Pierce; Sanjeev Sabharwal
Journal:  Acta Orthop       Date:  2014-04       Impact factor: 3.717

4.  Infected forearm nonunion treated by bone transport after debridement.

Authors:  Tang Liu; Zhenyang Liu; Lin Ling; Xiangsheng Zhang
Journal:  BMC Musculoskelet Disord       Date:  2013-09-22       Impact factor: 2.362

5.  Lengthening of free fibular grafts for reconstruction of the residual leg length discrepancy.

Authors:  Xianghong Zhang; Tingting Zhang; Tang Liu; Zhihong Li; Xiangsheng Zhang
Journal:  BMC Musculoskelet Disord       Date:  2019-02-08       Impact factor: 2.362

6.  Strontium‑containing α‑calcium sulfate hemihydrate promotes bone repair via the TGF‑β/Smad signaling pathway.

Authors:  Zhi Liu; Zewei Yu; Hong Chang; Yu Wang; Haibo Xiang; Xianrong Zhang; Bin Yu
Journal:  Mol Med Rep       Date:  2019-08-20       Impact factor: 2.952

7.  Surgical Treatment of an Infected Nonunion of the Middle Third of the Femur Associated with Femoral Shortening in a Hemophilia Patient.

Authors:  Ahmet Salduz; Özcan Kaya; Halil İbrahim Balci; Turgut Akgul; Fatih Dikici; Bülent Zülfikar; Mehmet Kocaoğlu
Journal:  Case Rep Orthop       Date:  2016-03-17

8.  Effect of Low-Frequency Pulsed Ultrasound on Drug Delivery, Antibacterial Efficacy, and Bone Cement Degradation in Vancomycin-Loaded Calcium Phosphate Cement.

Authors:  Mingmin Shi; Lei Chen; Yangxin Wang; Wei Wang; Shigui Yan
Journal:  Med Sci Monit       Date:  2018-02-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.